Cerebras Systems enters the second half of July in a genuinely interesting position: the stock just jumped 18% in a single session, yet options traders are more defensively positioned than at almost any point in the past year — and short sellers have been quietly rebuilding since a post-earnings selloff.
The clearest tension sits in options. The put/call ratio has climbed to 0.81, more than two standard deviations above its 20-day mean of 0.64 — the second-highest defensive reading recorded in the past year, with only the 52-week peak of 0.92 topping it. That jump coincided with the stock's 18% single-day rally on July 21, suggesting investors moved quickly to hedge gains rather than chase them. The defensive posture looks reactive rather than pre-emptive, but it remains elevated enough to be worth noting.
The lending market tells a story of gradual loosening after a period of extreme tightness. Through most of June and into early July, borrow availability was effectively zero — every share in the lending pool lent out, with utilisation hitting 100% across multiple consecutive sessions. That picture has eased materially: availability has recovered to roughly 11.5% now, and the cost to borrow has dropped from a peak near 4.2% in late June to below 2% this week. Short interest in raw share terms has crept up about 4% on the week and 19% over the past month to approximately 11.7 million shares, though the absence of a reliable free-float figure makes a precise percentage calculation unavailable. What is clear is that shorts were not squeezed out — they appear to have rebuilt steadily once borrow came back online. The ORTEX short score of 67.5 is consistent with a name carrying meaningful short-side conviction.
The analyst community is broadly constructive, but the Street's enthusiasm has been stress-tested by the June earnings reaction. After Q1 results on June 23, the stock fell nearly 19% on the day before recovering almost all of that loss within the following week. Most analysts held or lifted targets in the wake of that print: UBS raised to $320, Morgan Stanley moved to $273, Wedbush nudged to $280, while Needham and Rosenblatt both held at $300 and $275 respectively. The one outlier came from Freedom Capital Markets, which initiated with a Hold at $209 — almost exactly where the stock trades today at $208.57. The consensus remains Buy, with a mean target of $291, implying meaningful return potential from current levels. Bulls point to Cerebras's wafer-scale architecture and momentum in sovereign and enterprise AI workloads. Bears flag the customer concentration risk — OpenAI and AWS together represent a substantial portion of revenue — and warn that the current growth trajectory may compress as competition from established GPU vendors intensifies. The valuation is not cheap: the stock changed hands today at a price-to-book of roughly 7.8x, and the price-to-earnings multiple is in the thousands, reflecting near-zero current profitability against high growth expectations.
Ownership is concentrated among early-stage backers and a handful of institutional names. FMR (Fidelity) added a significant position as of June 30, reporting 28.8 million shares — the largest single institutional holder. CEO-adjacent and insider flows lean net positive over the past 90 days in aggregate, though the COO, Dhiraj Mallick, sold shares on multiple occasions in late June at prices between $162 and $207, and the Chief Accounting Officer trimmed modest amounts in the same window. The trades carry low significance scores and look consistent with planned disposals rather than a change in fundamental outlook.
The next earnings event is scheduled for September 22. Given that the last two prints produced a combined pattern of a sharp single-day drop followed by a full recovery within five days, the setup heading into that date — how far the stock has run, whether availability tightens again, and whether the put/call ratio sustains its elevated level — will be the metrics to track between now and then.
See the live data behind this article on ORTEX.
Open CBRS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
